Fiona McLaughlin

Chief Tech/Sci/R&D Officer at THALIA THERAPEUTICS PLC

56 year

Health Technology

Consumer Services

Finance

Profile

Fiona McLaughlin is currently Non-Executive Director at Hox Therapeutics Ltd. since 2023 and Head-Research & Development at Thalia Therapeutics Plc starting in 2025.
Former roles include Chief Scientific Officer-Therapeutics Division at Avacta Group Plc from 2021 to 2024, Vice President-New Opportunities at Algeta ASA from 2011 to 2014, Vice President-Translational Research at Sarossa Capital Ltd. from 2007 to 2010, and Director-Pre Clinical Development at BTG Ltd. from 2003 to 2006.
Education includes undergraduate studies at the University of Glasgow and a doctorate from the University of Cambridge.

Fiona McLaughlin active positions

Companies	Position	Start
THALIA THERAPEUTICS PLC	Chief Tech/Sci/R&D Officer	2025-05-26
Hox Therapeutics Ltd. Hox Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for cancer diseases based on the role of HOX genes	Director/Board Member	2023-11-30

All active positions of Fiona McLaughlin

Former positions of Fiona McLaughlin

Companies	Position	End
AVACTA GROUP PLC	Chief Tech/Sci/R&D Officer	2024-05-31
ALGETA ASA	Corporate Officer/Principal	2014-03-31
Sarossa Capital Ltd. Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services	Corporate Officer/Principal	2010-06-30
BTG	Chief Tech/Sci/R&D Officer	2005-12-31

See the detail of Fiona McLaughlin's experience

Training of Fiona McLaughlin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fiona McLaughlin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
BTG Ltd. BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders	Health Technology
Sarossa Capital Ltd. Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services	Finance
University of Glasgow University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avacta Group Plc Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables	Commercial Services
Algeta ASA Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer	Health Technology
N4 Pharma Plc N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance	Health Technology
Hox Therapeutics Ltd. Hox Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for cancer diseases based on the role of HOX genes	Health Technology